UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2022 OR ☐ Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 COMMISSION FILE NUMBER 001-38661 Elanco Animal Health Incorporated (Exact name of Registrant as specified in its charter) INDIANA 82-5497352 (State or other jurisdiction of (I.R.S. Employer incorporation or ...

Elanco Animal Health Incorporated (NYSE:ELAN) Q1 2022 Earnings Conference Call May 9, 2022 8:00 AM ET Company Participants Katy Grissom - Head of IR Jeffrey Simmons - CEO Todd Young - CFO Conference Call Participants Erin Wright - Morgan Stanley Michael Ryskin - BofA Securities Merrill Lynch Nathan Rich - Goldman Sachs Chris Scott - JPMorgan Umer Raffat - Evercore ISI Michael Parolari - Raymond James Jonathan Block - Stifel Balaji Prasad - Barclays Steve Scala - Cowen Christine Raines - William Blair Opera ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2022 OR ☐ Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 COMMISSION FILE NUMBER 001-38661 Elanco Animal Health Incorporated (Exact name of Registrant as specified in its charter) INDIANA 82-5497352 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ANNUAL REPORT UNDER SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Commission file number 001-38661 Elanco Animal Health Incorporated (Exact name of Registrant as specified in its charter) INDIANA 82-5497352 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 2500 INNOVATION WAY, GREENFIELD, INDIANA 46140 (Address of princip ...

Elanco Animal Health Incorporated (NYSE:ELAN) Q4 2021 Earnings Conference Call February 24, 2022 8:30 AM ET Company Participants Katy Grissom - Head of IR Jeff Simmons - CEO Todd Young - CFO Ellen de Brabander - EVP of Innovation and Regulatory Affairs Scott Purucker - IR Conference Call Participants Erin Wright - Morgan Stanley Michael Ryskin - Bank of America Nathan Rich - Goldman Sachs Chris Schott - JPMorgan Umer Raffat - Evercore ISI Jon Block - Stifel Elliot Wilbur - Raymond James Noven Cai - Citi Ope ...

Elanco Animal Health Incorporated (NYSE:ELAN) Q3 2021 Earnings Conference Call November 5, 2021 8:00 AM ET Company Participants Jeff Simmons – CEO Todd Young – CFO Tiffany Kanaga – Head of Investor Relations Scott Purucker – Investor Relations Conference Call Participants Michael Ryskin – Bank of America Michael Difiore – Evercore ISI Nathan Rich – Goldman Sachs Chris Schott – JPMorgan Jon Block – Stifel Balaji Prasad – Barclays John Kreger – William Blair Elliot Wilbur – Raymond James Noven Cai – Citi Davi ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2021 OR ☐ Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 COMMISSION FILE NUMBER 001-38661 Elanco Animal Health Incorporated (Exact name of Registrant as specified in its charter) INDIANA 82-5497352 (State or other jurisdiction of (I.R.S. Employer incorporation or organizat ...

Elanco Animal Health Incorporated (NYSE:ELAN) Q2 2021 Earnings Conference Call August 9, 2021 8:00 AM ET Company Participants Tiffany Kanaga - Investor Relations Jeff Simmons - President & Chief Executive Officer Todd Young - Chief Financial Officer Conference Call Participants Jon Block - Stifel Elliot Wilbur - Raymond James Michael Ryskin - Bank of America Nathan Rich - Goldman Sachs Umer Raffat - Evercore ISI Balaji Prasad - Barclays Operator Ladies and gentleman, thank you for standing by, and welcome t ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2021 OR ☐ Transition Report Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934 COMMISSION FILE NUMBER 001-38661 Elanco Animal Health Incorporated (Exact name of Registrant as specified in its charter) INDIANA 82-5497352 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) ...

Kindred Biosciences, Inc. (KIN) Q1 2021 Results Conference Call May 11, 2021 4:30 PM ET Company Participants Dr. Richard Chin - CEO Wendy Wee - CFO Katja Buhrer - VP of Corporate Development and IR Conference Call Participants Trevor Brown - Stifel Ben Haynor - Alliance Global Balaji Prasad - Barclays Brandon Folkes - Cantor Fitzgerald John Lee - H.C. Wainwright David Westenberg - Guggenheim Securities Operator Welcome to the First Quarter 2021 Financial Results Conference Call and Webcast for Kindred Biosc ...